237 related articles for article (PubMed ID: 31131446)
21. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
22. Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma.
Patel KB; Padhya TA; Huang J; Hernandez-Prera JC; Li T; Chung CH; Wang L; Wang X
Mol Carcinog; 2023 Apr; 62(4):493-502. PubMed ID: 36636912
[TBL] [Abstract][Full Text] [Related]
23. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
24. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
[TBL] [Abstract][Full Text] [Related]
25. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma.
Bunbanjerdsuk S; Vorasan N; Saethang T; Pongrujikorn T; Pangpunyakulchai D; Mongkonsiri N; Arsa L; Thokanit N; Pongsapich W; Anekpuritanang T; Ngamphaiboon N; Jinawath A; Sunpaweravong S; Pisitkun T; Suktitipat B; Jinawath N
Mod Pathol; 2019 Jul; 32(7):943-956. PubMed ID: 30737471
[TBL] [Abstract][Full Text] [Related]
26. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
Wang YL; Zhang YY
Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
[TBL] [Abstract][Full Text] [Related]
27. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
Chen G; Wang Y; Wang L; Xu W
Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of DNA methylation for head and neck cancer varies by sample type and number of markers tested.
Ji X; Guan C; Jiang X; Li H
Oncotarget; 2016 Nov; 7(48):80019-80032. PubMed ID: 27683120
[TBL] [Abstract][Full Text] [Related]
29. Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Sailer V; Charpentier A; Dietrich J; Vogt TJ; Franzen A; Bootz F; Dietrich D; Schroeck A
PLoS One; 2018; 13(2):e0192742. PubMed ID: 29425237
[TBL] [Abstract][Full Text] [Related]
30. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
31. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
[TBL] [Abstract][Full Text] [Related]
32. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.
Kostareli E; Hielscher T; Zucknick M; Baboci L; Wichmann G; Holzinger D; Mücke O; Pawlita M; Del Mistro A; Boscolo-Rizzo P; Da Mosto MC; Tirelli G; Plinkert P; Dietz A; Plass C; Weichenhan D; Hess J
Epigenetics; 2016; 11(1):61-73. PubMed ID: 26786582
[TBL] [Abstract][Full Text] [Related]
33. NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.
Virani S; Bellile E; Bradford CR; Carey TE; Chepeha DB; Colacino JA; Helman JI; McHugh JB; Peterson LA; Sartor MA; Taylor JM; Walline HM; Wolf GT; Rozek LS
BMC Cancer; 2015 Oct; 15():825. PubMed ID: 26518708
[TBL] [Abstract][Full Text] [Related]
34. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
36. A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma.
Liu G; Zheng J; Zhuang L; Lv Y; Zhu G; Pi L; Wang J; Chen C; Li Z; Liu J; Chen L; Cai G; Zhang X
Sci Rep; 2018 Oct; 8(1):15250. PubMed ID: 30323196
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
38. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Xing L; Zhang X; Guo M; Zhang X; Liu F
DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
40. ECE-1 overexpression in head and neck cancer is associated with poor tumor differentiation and patient outcome.
Xu ES; Yang MH; Huang SC; Liu CY; Yang TT; Chou TY; Hwang TZ; Hsu CT
Oral Dis; 2019 Jan; 25(1):44-53. PubMed ID: 29978582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
